Detalhe da pesquisa
1.
Primary Chemoablation of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer Using UGN-102, a Mitomycin-Containing Reverse Thermal Gel (Optima II): A Phase 2b, Open-Label, Single-Arm Trial.
J Urol
; 207(1): 61-69, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34433303
2.
Randomized clinical trials towards a single-visit cure for chronic hepatitis C: Oral GSK2878175 and injectable RG-101 in chronic hepatitis C patients and long-acting injectable GSK2878175 in healthy participants.
J Viral Hepat
; 27(7): 699-708, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32096313
3.
Targeting B-cell maturation antigen with GSK2857916 antibody-drug conjugate in relapsed or refractory multiple myeloma (BMA117159): a dose escalation and expansion phase 1 trial.
Lancet Oncol
; 19(12): 1641-1653, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30442502
4.
A phase II study of lapatinib and bevacizumab as treatment for HER2-overexpressing metastatic breast cancer.
Breast Cancer Res Treat
; 134(1): 13-20, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22198412